HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierluigi Strippoli Selected Research

Down Syndrome Critical Region

1/2021Structural Characterization of the Highly Restricted Down Syndrome Critical Region on 21q22.13: New KCNJ6 and DSCR4 Transcript Isoforms.
1/2008Identification and analysis of human RCAN3 (DSCR1L2) mRNA and protein isoforms.
5/2006Proteins encoded by human Down syndrome critical region gene 1-like 2 (DSCR1L2) mRNA and by a novel DSCR1L2 mRNA isoform interact with cardiac troponin I (TNNI3).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierluigi Strippoli Research Topics

Disease

5Neoplasms (Cancer)
08/2010 - 04/2004
4Colonic Neoplasms (Colon Cancer)
08/2010 - 10/2004
3Down Syndrome Critical Region
01/2021 - 05/2006
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 08/2010
2Down Syndrome (Down's Syndrome)
01/2021 - 01/2019
2Intellectual Disability (Idiocy)
01/2019 - 01/2018
2Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2007 - 05/2006
2Osteosarcoma (Osteogenic Sarcoma)
04/2004 - 01/2002
1Crohn Disease (Crohn's Disease)
03/2011
1Carcinoid Tumor (Carcinoid)
05/2006
1Sarcoma (Soft Tissue Sarcoma)
06/2005
1Rhabdomyosarcoma
06/2005
1Mood Disorders (Mood Disorder)
07/2004
1Bipolar Disorder (Manic Depressive Psychosis)
07/2004
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
06/2003

Drug/Important Bio-Agent (IBA)

6Messenger RNA (mRNA)IBA
08/2010 - 01/2002
5Complementary DNA (cDNA)IBA
08/2010 - 01/2002
5Proteins (Proteins, Gene)FDA Link
01/2008 - 06/2003
3Protein Isoforms (Isoforms)IBA
01/2021 - 05/2006
3RNA (Ribonucleic Acid)IBA
01/2021 - 10/2004
3RNA IsoformsIBA
04/2007 - 05/2006
2CarbonIBA
01/2021 - 01/2019
2Galectin 4 (LGALS4)IBA
01/2018 - 10/2004
1Intergenic DNA (Junk DNA)IBA
01/2021
1PotassiumIBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
15,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA
01/2019
1alpha2 Subunit Collagen Type IIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
05/2016
1Interleukin-23 (Interleukin 23)IBA
03/2011
1CaspasesIBA
03/2011
1NucleotidesIBA
03/2011
1Cetuximab (Erbitux)FDA Link
08/2008
1Epidermal Growth Factor (EGF)IBA
08/2008
1Gefitinib (Iressa)FDA Link
08/2008
1CalcineurinIBA
01/2008
1Amino AcidsFDA Link
04/2007
1Tyrosine (L-Tyrosine)FDA Link
04/2007
1Cysteine (L-Cysteine)FDA Link
04/2007
1Troponin IIBA
05/2006
1Insulin-Like PeptidesIBA
05/2006
1NeuropeptidesIBA
05/2006
1Small Interfering RNA (siRNA)IBA
06/2005
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2005
1GlycosyltransferasesIBA
10/2004
1villinIBA
10/2004
1Uridine Diphosphate (UDP)IBA
10/2004
1Peptides (Polypeptides)IBA
10/2004
1Glycoproteins (Glycoprotein)IBA
10/2004
1Glutathione PeroxidaseIBA
10/2004
1GastrinsIBA
10/2004
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2004
1ElementsIBA
10/2004
1CalciumIBA
10/2004
1Trefoil Factor-3IBA
10/2004
1Bone Morphogenetic Protein 4IBA
10/2004
1Cyclin DIBA
10/2004
1Glutamate Receptors (Glutamate Receptor)IBA
07/2004
1RNA Precursors (Precursor, mRNA)IBA
07/2004
1Biological ProductsIBA
04/2004
1Alkaline PhosphataseIBA
04/2004
1Transfer RNA (tRNA)IBA
06/2003
1pseudouridine synthasesIBA
06/2003

Therapy/Procedure

1Aftercare (After-Treatment)
01/2019
1Therapeutics
01/2018